Cutting nitrous oxide waste in hospitals, switching to reusable vaginal speculums for cervical screening, and prescribing tablets over intravenous drugs are just some of the tangible actions doctors can take to reduce the carbon footprint of healthcare.
Omalizumab biosimilar by Curateq Biologics for Asthma: Likelihood of Approval
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug